Prognostic value of the FBG/HDL-C ratio for 28-day all-cause mortality in critically ill patients: a retrospective cohort study with external validation

Key Points

• The study aims to evaluate the prognostic value of the FBG/HDL-C ratio in predicting short-term mortality among critically ill patients.
• Conducted a retrospective cohort study of critically ill patients with FBG and HDL-C measurements.
• Performed external validation to assess generalizability of the findings.
• Analyzed the association between FBG/HDL-C ratio and mortality rates.
• Found an independent association between higher FBG/HDL-C ratios and increased all-cause mortality.
• Suggested the ratio may serve as an additional tool for risk stratification despite limitations in routine HDL-C testing.